First Eagle Investment's BIO Position Overview
First Eagle Investment (via First Eagle Investment Management, LLC) currently holds 2.61 M shares of Bio-Rad Laboratories, Inc. (BIO) worth $765.21 M, representing 1.28% of the portfolio. First purchased in 1970-Q1, this long-term strategic position has been held for 226 quarters.
Based on 13F filings since 2013, First Eagle Investment has maintained a long-term strategic position in BIO, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2025, adding 951,123 shares. Largest reduction occurred in Q2 2023, reducing 17.59 M shares.
Analysis based on 13F filings available since 2013 Q2
First Eagle Investment's Bio-Rad Laboratories (BIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Rad Laboratories (BIO) Trades by First Eagle Investment
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +3,447 | Add 0.13% | 2.61 M | $293.61 |
| Q1 2026 | +32,299 | Add 1.26% | 2.6 M | $278.75 |
| Q4 2025 | +50,154 | Add 1.99% | 2.57 M | $302.99 |
| Q3 2025 | +3,006 | Add 0.12% | 2.52 M | $280.39 |
| Q2 2025 | +951,123 | Add 60.73% | 2.52 M | $241.32 |
| Q1 2025 | +852,685 | Add 119.51% | 1.57 M | $243.56 |
| Q4 2024 | +505 | Add 0.07% | 713,505 | $328.51 |
| Q3 2024 | +76,725 | Add 12.06% | 713,000 | $334.58 |
| Q2 2024 | +634,311 | Add 32296.89% | 636,275 | $273.11 |
| Q1 2024 | +1,485 | Add 310.02% | 1,964 | $345.87 |
| Q4 2023 | +21 | Add 4.59% | 479 | $322.89 |
| Q3 2023 | +267 | Add 139.79% | 458 | $358.45 |
| Q2 2023 | +191 | New Buy | 191 | $379.12 |
| Q1 1970 | +17.59 M | Add 0.00% | 17.59 M | $43.50 |
First Eagle Investment's Bio-Rad Laboratories Investment FAQs
First Eagle Investment first purchased Bio-Rad Laboratories, Inc. (BIO) in Q1 1970, acquiring 17,591,978 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
First Eagle Investment has held Bio-Rad Laboratories, Inc. (BIO) for 226 quarters since Q1 1970.
First Eagle Investment's largest addition to Bio-Rad Laboratories, Inc. (BIO) was in Q1 1970, adding 17,591,978 shares worth $765.21 M.
According to the latest 13F filing for Q2 2026, First Eagle Investment's firm, First Eagle Investment Management, LLC, owns 2,606,219 shares of Bio-Rad Laboratories, Inc. (BIO), valued at approximately $765.21 M.
As of the Q2 2026 filing, Bio-Rad Laboratories, Inc. (BIO) represents approximately 1.28% of First Eagle Investment's publicly disclosed stock portfolio, making it one of their key holdings.
First Eagle Investment's peak holding in Bio-Rad Laboratories, Inc. (BIO) was 17,591,978 shares, as reported at the end of Q1 1970.